Rituximab is associated with an increased risk of malaria among adult lymphoma patients in Malawi: a prospective observational cohort
Authors:
- Luke EastburgLELuke Eastburg
- Sneha Ashish MakhijaniSMSneha Ashish Makhijani
- Catherine Suzanne ForconiCFCatherine Suzanne Forconi
- Dominic MooreDMDominic Moore
- Oksana KharaboraOKOksana Kharabora
- Edwards KasonkanjiEKEdwards Kasonkanji
- Coxcilly KampaniCKCoxcilly Kampani
- Maria ChikasemaMCMaria Chikasema
- Sophia Maharry RoushSRSophia Maharry Roush
- Stephen Mburu KimaniSKStephen Mburu Kimani
- Yuri FedoriwYFYuri Fedoriw
- Jonathan James JulianoJJJonathan James Juliano
Open Access
- 20 November 2025
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 90
Abstract
No abstract availableKeywords
Funding Information
- Fogarty International Center (K01TW011470)
- National Cancer Institute (U54CA254564)
- National Cancer Institute (U54CA190152)
- National Institutes of Health
- U.S. Department of Health and Human Services
- Universidad Nacional de Córdoba
- Division of Microbiology and Infectious Diseases (K24AI134990)
This publication has 40 references indexed in Scilit:
- Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximabAnnals of Allergy, Asthma & Immunology, 2023
- Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patientsJournal of Allergy and Clinical Immunology, 2021
- Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal DiseasesArthritis & Rheumatology, 2019
- Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and HypogammaglobulinemiaJAMA Network Open, 2018
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune diseaseJournal of Autoimmunity, 2015
- MalariaThe Lancet, 2014
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent InfectionsClinical Lymphoma Myeloma and Leukemia, 2013
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trialArthritis & Rheumatism, 2009
- Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparumTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001